This Article Full Text Full Text (PDF) All Versions of this Article: 38/3/1031    most recent 01.STR.0000257966.32242.0bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilhelm-Schwenkmezger, T. Articles by Nedelmann, M. Search for Related Content PubMed PubMed Citation Articles by Wilhelm-Schwenkmezger, T. Articles by Nedelmann, M. Related Collections Embolic stroke Thrombolysis Other Stroke

(Stroke. 2007;38:1031.)
© 2007 American Heart Association, Inc.

Original Contributions

Therapeutic Application of 20-kHz Transcranial Ultrasound in an Embolic Middle Cerebral Artery Occlusion Model in Rats

Safety Concerns

Thomas Wilhelm-Schwenkmezger, MD; Patrick Pittermann, MD; Katharina Zajonz; Oliver Kempski, MD; Marianne Dieterich, MD Max Nedelmann, MD

From the Department of Neurology (T.W.-S., P.P., K.Z., M.D.) and the Institute for Neurosurgical Pathophysiology (O.K.), Johannes Gutenberg University, Mainz, Germany; and the Department of Neurology (M.N.), Justus Liebig University, Giessen, Germany.

Correspondence to Max Nedelmann, MD, Department of Neurology, Justus Liebig University, Am Steg 14, 35392 Giessen, Germany. E-mail max.nedelmann{at}neuro.med.uni-giessen.de

Background and Purpose— Therapeutic application of diagnostic ultrasound has been shown to improve recanalization rates in patients with acute cerebral vessel occlusion. There is experimental evidence that low-frequency ultrasound may be superior. This study was designed to evaluate the therapeutic efficacy and safety of low-frequency ultrasound in an embolic middle cerebral artery occlusion model in rats. A parameter setting was used that had not previously shown any side effects and interactions with healthy rat brain tissue.

Methods— Male Wistar rats were submitted to middle cerebral artery clot embolism and transcranial treatment with 20-kHz continuous-wave ultrasound (0.2 W/cm²), either alone or in combination with recombinant tissue-type plasminogen activator. Control groups received no treatment or recombinant tissue-type plasminogen activator alone. Outcome assessment consisted of determination of infarct volume and neurological evaluation.

Results— Eleven animals treated with ultrasound died during the follow-up period of 7 days, compared with 2 animals in the control groups (P=0.028). In 3 animals, subarachnoid hemorrhage was detected (1 in the control group). The other animals that died displayed secondary worsening after an initial period of normal vigilance. Histological examination revealed massive edema formation. In surviving animals, no benefit of treatment could be demonstrated.

Conclusions— In this study, 20-kHz continuous-wave ultrasound caused death in a significant number of animals. Ultrasound at 20 kHz does not seem to be suitable for transcranial therapeutic cerebral application. The data underline the necessity to obtain further animal data to establish the safety limits of frequency and power output.

Key Words: efficacy • safety • stroke • thrombolysis • ultrasound

This article has been cited by other articles:

				T. Saguchi, H. Onoue, M. Urashima, T. Ishibashi, T. Abe, and H. Furuhata Effective and Safe Conditions of Low-Frequency Transcranial Ultrasonic Thrombolysis for Acute Ischemic Stroke: Neurologic and Histologic Evaluation in a Rat Middle Cerebral Artery Stroke Model Stroke, March 1, 2008; 39(3): 1007 - 1011. [Abstract] [Full Text] [PDF]

				A. B. Singhal and E. H. Lo Advances in Emerging Nondrug Therapies for Acute Stroke 2007 Stroke, February 1, 2008; 39(2): 289 - 291. [Full Text] [PDF]